Tag: Fda recall

In April 2020, the U.S. Food and Drug Administration (FDA) requested that all ranitidine products, including the popular brand-name Zantac, be pulled from the market. This action answers the question, **what antacid was discontinued?**, and followed an investigation that discovered a probable human carcinogen in the medication.

First introduced in 1957, the prescription painkiller propoxyphene was a widely used opioid for decades, appearing in medications such as Darvon and Darvocet. Despite its long history, the drug was voluntarily withdrawn from the U.S. market in 2010 after new data revealed serious and fatal cardiac side effects.

In 2010, the U.S. Food and Drug Administration (FDA) requested a voluntary market withdrawal of all propoxyphene-containing medications due to serious and potentially fatal cardiac toxicity, confirming that this drug's limited benefits were outweighed by its significant risks. For those wondering, **is propoxyphene stronger than hydrocodone?**, the answer is a resounding no, as hydrocodone is significantly more potent and remains a currently prescribed opioid for pain management.

Over 20 million prescriptions for Darvocet were written in 2007 alone, but in 2010, the U.S. Food and Drug Administration (FDA) recalled all products containing its active ingredient, propoxyphene, due to serious and potentially fatal heart risks. As a result, the question, 'Is Darvocet better than tramadol?', is decisively answered by Darvocet’s removal from the market.

The acronym PPX can refer to several different substances in the medical field, with one notable example being propoxyphene, an opioid pain reliever that the FDA requested be withdrawn from the U.S. market in 2010 due to serious heart rhythm abnormalities. Understanding which medication or therapy is being referenced requires knowing the specific context, as the term applies to discontinued painkillers, regenerative treatments, and cancer drugs.

In 2012, K-Y Liquibeads were temporarily removed from the market following a regulatory request by the U.S. Food and Drug Administration (FDA). This recall caused widespread consumer confusion, leading many to believe the product was permanently discontinued. However, this is not the case, as the product has since been reformulated and is widely available today.

In April 2020, the U.S. Food and Drug Administration (FDA) requested that all ranitidine products, commonly known by the brand name Zantac, be removed from the market immediately. This was due to concerns about the potential for unsafe levels of a probable human carcinogen called N-Nitrosodimethylamine (NDMA) to develop in the medication. If you're wondering if Zantac is safe to take now, the answer depends on which version you are referring to.

In April 2020, the U.S. Food and Drug Administration (FDA) requested the immediate withdrawal of all ranitidine drugs, commonly known by the brand name Zantac, from the market due to the presence of a probable human carcinogen. If you have been asking, 'What is this pill L852?', the answer is ranitidine hydrochloride 150 mg, and its use is no longer advised.

Heightened awareness of eye drop safety has led many to ask, 'Has Muro 128 ointment been recalled?' While there's no *current* recall for Muro 128 ointment as of September 2025, a past recall and recent issues with other brands have caused confusion.

In 2020, the U.S. Food and Drug Administration (FDA) requested the immediate market withdrawal of all prescription and over-the-counter ranitidine products. This action effectively banned the popular acid reflux medicine, commonly known by the brand name Zantac, from the U.S. market due to potential contamination with a cancer-causing impurity.